Biotech

All Articles

Analysts dig into Avidity's DMD succeed, revealing nuances in information

.Avidity Biosciences pleased entrepreneurs with phase 1/2 records in Duchenne muscle dystrophy (DMD)...

Actinogen's cortisol blocker fails period 2 depression research

.Actinogen Medical's cortisol blocker has skipped the main endpoint of a period 2 research in clinic...

Bivictrix determines going private only method to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have gone to the facility of a lot of a billion-dollar biobuck lice...

TPG tops up funds to $580M for assets all over life scientific researches

.Asset manager TPG, which has supported biotechs like Sionna Therapies and Santa Clam Ana Biography,...

Merck quits phase 3 TIGIT test in lung cancer for futility

.Merck &amp Co.'s TIGIT plan has actually experienced another misfortune. Months after shuttering a ...

After a hard year, Exscientia folds up in to Recursion

.After a year determined by pipeline hairstyles, the shift of its own chief executive officer as wel...

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Rehab was actually impressed sufficient with Harbour BioMed's bispecific immune reactor th...

A better consider Ferocious Biotech's Ferocious 15

.In this particular week's incident of "The Best Pipe," our experts are actually diving right into S...

Lilly experiences stage 2 failure of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party celebrating the commendation of Alzheim...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings...